CAS: 38517-23-6; (S)-2-Stearamidopentanedioic Acid Monosodium Salt
该化合物是一种表面活性剂和乳化剂,通常用于化妆品和食品行业,是一种来自氨酸抗糖酸和硫酸盐的钠盐,有助于其非phyply特性,使其与水利物质和缺水物质相互作用,其特点是能够稳定乳液,增加质质质和改善配方的可传播性.该产品被普遍承认为在食品和化妆品中安全使用,并且可以生物降解,因此是一种环境友好的选择.此外,它具有温和性,适合敏感的皮肤应用,水中的溶性以及与其他各种成分的兼容性进一步提高了其配方中的效用.总体而言,其功能性和安全性能对硫酸糖酸酯进行了评估,有助于其在各种应用中广泛使用.
- 英文名称(S)-2-Stearamidopentanedioic Acid Monosodium Salt
- 中文名称硬脂酰谷氨酸钠
- IUPAC名称stearoyl-L-glutamic acid, sodium salt
- 其它别名L-Glutamic Acid, N-(1-Oxooctadecyl)-, Monosodium Salt; L-Glutamic Acid, N-(1-Oxooctadecyl)-, Monosodium Salt(9Ci); L-Glutamic Acid,N-(1-Oxooctadecyl)-,Monosodium Salt; Sodium Hydrogen N-(1-Oxooctadecyl)-L-Glutamate; Sodium Stearoyl Glutamate; L-Glutamic Acid,N-(1-Oxooctadecyl)-,Monosodium Salt(9Ci); N-(1-Oxooctadecyl)-L-Glutamic Aci Monosodium Salt; Sodium N-Stearoyl L-Glutamate,Sodium Stearoyl Glutamate
- CAS编号38517-23-6
- EINECS号:253-980-9
- FDA UNII编号:65A9F4P024
- 分子式:C23H43NNaO5分子量:436.59
- 产品CID: 1397392
- 产品分类生物化工 → 氨基酸及其衍生物 → 谷氨酸类衍生物
MSDS等安全信息
- GHS象形图
- GHS符号GHS07;
注释: Exclamation mark - 危险类别严重眼刺激 类别2
水生慢性毒性 类别3 - 警示词Warning(警告)
- 危险描述H319 |造成严重眼刺激.
H412 |对水生生物有害并具有长期持续影响. - 防范说明P264-P280-P305+P351+P338-P337+P313P
- 安全声明The panel concluded that the 115 amino acid alkyl amides listed below are safe in the present practices of use and concentration in cosmetics, when formulated to be non-irritating...Sodium Stearoyl Glutamate... | Safe for use in cosmetics, with qualifications
欧盟法规
ECHA物质C&L通报REACH预注册合成工艺路线路线简述
海关参考信息
- 2905121000-正丙醇
2905130000-正丁醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:CN-114031516-A
优先权日:2021-11-23
标题 :A kind of method for catalyzing synthesis of N-acyl amino acid surfactant based on zirconium catalyst
专利号:WO-2006053688-A1
优先权日:2004-11-17
标 题:Cosmetic and dermatological preparations for the treatment of mature skin
发明人：DOERING THOMAS
权利人:HENKEL KGAA; DOERING THOMAS
摘要:The invention relates to topical cosmetic or dermatological compositions for the treatment of mature or intrinsically or extrinsically aged skin, in particular, for anti-wrinkle treatment, containing a combination of at least two selected peptides in a suitable cosmetic or dermatological vehicle, which have an effect at differing points of the process of collagen and/or fibronectin synthesis.
专利号:WO-2006042625-A2
优先权日:2004-10-15
标 题 :Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators
专利号:EP-1799311-A2
优先权日:2004-10-15
标 题:Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators
专利号:US-10836791-B2
优先权日:2016-09-15
标题:Compounds
发明人：HEIDL MARC; JACKSON EILEEN
权利人:DSM IP ASSETS BV
摘要:The present invention relates to novel compounds which effectively inhibit the melanin synthesis in human melanocytes and are thus suitable for the treatment of senile lentigines, for smoothening skin color irregularities and/or for lightening natural skin color.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:S13 | EUCOSMETICS | Combined Inventory of Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006) | DOI:10.5281/zenodo.2624118
摘要:International Journal of Toxicology 36(Suppl. 1):17-56, 2017
📝 需求与反馈
尽可能描述清楚需求与问题信息
